905300-56-3

Basic information

• Product Name: Carbamic acid, (5-acetyl-2-thiazolyl)-, 1,1-dimethylethyl ester (9CI)
• Synonyms: Carbamic acid, (5-acetyl-2-thiazolyl)-, 1,1-dimethylethyl ester (9CI)
• CAS NO: 905300-56-3
• Molecular Formula: C10H14N2O3S
• Molecular Weight: 242.29
• Mol File: 905300-56-3.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Density: 1.257±0.06 g/cm3(Predicted)
• PKA: 4.85±0.70(Predicted)
• CAS DataBase Reference: Carbamic acid, (5-acetyl-2-thiazolyl)-, 1,1-dimethylethyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (5-acetyl-2-thiazolyl)-, 1,1-dimethylethyl ester (9CI)(905300-56-3)
• EPA Substance Registry System: Carbamic acid, (5-acetyl-2-thiazolyl)-, 1,1-dimethylethyl ester (9CI)(905300-56-3)

Safety Data

• Hazardous Substances Data: 905300-56-3(Hazardous Substances Data)

Upstream product

• 53159-71-0 1-(2-aminothiazol-5-yl)ethanone 
• 24424-99-5 di-tert-butyl dicarbonate 

Relevant articles and documents

1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE INHIBITORS

A compound of formula (I), wherein R, R1, R2, R3, Y, Y1, a, X, and Z are as defined herein. The compounds of the present invention are inhibitors of hematopoietic prostaglandin D synthase (H-PGDS) and can be useful in the treatment of Duchenne Muscular Dystrophy. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting H-PGDS activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.